AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 170 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $24,000 | +1100.0% | 1,576 | +471.0% | 0.00% | – |
Q2 2022 | $2,000 | -81.8% | 276 | -77.0% | 0.00% | – |
Q1 2022 | $11,000 | +450.0% | 1,200 | +300.0% | 0.00% | – |
Q4 2021 | $2,000 | – | 300 | +614.3% | 0.00% | – |
Q3 2020 | $0 | -100.0% | 42 | -82.6% | 0.00% | – |
Q1 2020 | $3,000 | -94.1% | 242 | -88.6% | 0.00% | – |
Q4 2019 | $51,000 | -96.1% | 2,125 | -96.9% | 0.00% | -100.0% |
Q3 2019 | $1,306,000 | -35.8% | 67,934 | -1.3% | 0.01% | -38.9% |
Q2 2019 | $2,033,000 | +14421.4% | 68,813 | +24388.6% | 0.02% | – |
Q3 2017 | $14,000 | -77.8% | 281 | -76.4% | 0.00% | -100.0% |
Q2 2017 | $63,000 | -22.2% | 1,191 | -33.2% | 0.00% | 0.0% |
Q1 2017 | $81,000 | -92.0% | 1,782 | -93.4% | 0.00% | -90.9% |
Q3 2016 | $1,018,000 | +785.2% | 26,971 | +472.0% | 0.01% | +1000.0% |
Q4 2015 | $115,000 | -85.2% | 4,715 | -89.2% | 0.00% | -90.9% |
Q3 2015 | $778,000 | +267.0% | 43,842 | +264.9% | 0.01% | +266.7% |
Q2 2015 | $212,000 | – | 12,014 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|